Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 25 October 2018
      Betting on innovation, the case for the SPC
 
 
A blog by Nathalie Moll
 
This is the third blog telling the story behind the EFPIA Manifesto, we have already explored Health Technology Assessment and transitioning to outcomes-focused health. I would like to dedicate this blog to maintaining and developing Europe’s Intellectual Property (IP) framework, in particular the Supplementary Protection Certificate (SPC). 

If we think of the challenges faced by healthcare systems under pressure from an ageing population and increased prevalence of chronic disease, then it is only through innovation leading to new solutions that we will have a chance to create a healthier future for Europe. IP rights and incentives are the foundations of medical innovation.

Read more →
 
 
      Blogs
 
  19 October 2018 #ForTheChance to take long mountain walks without the fear of stumbling and fracturing my bones...

A guest blog from Hanneke, living with fragility fractures caused by Osteoporosis

Read more →
 
 
 
  22 October 2018 Value Based Health Care (VBH) Outcomes Workshop: A Health Systems Approach

Join us on 15 November 2018 in London to further debate and understand the principles of Value Based Healthcare with...

Read more →
 
 
 
  15 October 2018 #WeWontRest until people with rare diseases get faster access to medicines, based on innovative...

A guest blog by Kim Stratton, Head of International Commercial at Shire

Read more →
 
 
 
  23 October 2018 Valued collaborations with patient organizations

A guest blog by Allan Hillgrove, Member of the Board of Managing Directors, Boehringer Ingelheim

Read more →
 
 
 
      Videos
 
 
 
IMI 10th anniversary video series: The Story of the Innovative Medicines Initiative
Featuring: Rudolf Strohmeier, Director-General of the Publications Office of the European Union and Former Chair of the IMI Governing Board; Nathalie Moll, Director-General, EFPIA.
 
 
IMI 10th anniversary video series: IMI Project Participant Testimonial - Academia
Featuring: Prof. Peter Sterk, U-BIOPRED Coordinator, The University of Amsterdam
 
 
 
 
      What we are reading
5 questions for the future of cancer research 25 October 2018  (POLITICO) Read more →
Does fast-track drugs approval in EU run too fast? 25 October 2018  (EurActiv) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe